Skip to content

Trial · Interventional

CompletedNot applicableResults postedRegistry data

A Randomized Trial of Induction Versus Expectant Management

Short name ARRIVE

NCTNCT01990612 (opens ClinicalTrials.gov in a new tab)Other idHD36801-ARRIVEOther idUG1HD027869Other idUG1HD027915Other idUG1HD034116

This trial does not test a peptide that PepBank tracks.

  • Measures Oxytocin, does not give it. It appears in an outcome measure.

Overview

Status
Completed
Phase
Not applicable
Enrollment
6,106 participants (actual)
Sponsor
The George Washington University Biostatistics Center · Other
Design
Randomized · Open label (no masking)
Countries
1 country

United States

Start
Mar 2014
Primary completion
Nov 2017
Completion
Jan 2018
First posted
21 Nov 2013 (estimated)
Last update posted
21 Feb 2019
Conditions
Labor and Delivery

Timeline

1 trial · 1 completed · 1 with posted results

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
201420152016201720182019
  1. N/A

    ARRIVE

    NCT01990612

    Mar 2014 to Jan 2018

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

A randomized clinical trial to assess whether elective induction of labor at 39 weeks of gestation compared with expectant management will improve outcomes.

Interventions

  • Elective Induction of LaborProcedure

Arms2

  • No intervention

    Expectant Management

    Expectant management (unless a medical indication arises) until at least 40 weeks 5 days.

  • Other

    Elective Induction of Labor

    Elective induction of labor between 39 weeks 0 days and 39 weeks 4 days

Primary outcomes11

Outcomes the sponsor listed as primary.

  1. Composite of Severe Neonatal Morbidity and Perinatal Mortality

    Time frame · delivery through 72 hours after birth

    Registry description

    Includes any one of: * Perinatal death * Need for respiratory support within 72 hours after birth * Apgar score of 3 or less at 5 minutes * Hypoxic-ischemic encephalopathy * Seizure * Infection (confirmed sepsis or pneumonia) * Meconium aspiration system * Birth trauma (bone fracture, neurologic injury or retinal hemorrhage) * Intracranial or subaleal hemorrhage * Hypotension requiring vasopressor support

  2. Perinatal Death (Component of Primary Outcome)

    Time frame · antepartum pregnancy period through hospital discharge

    Registry description

    Perinatal death includes antepartum stillbirth, intrapartum stillbirth and neonatal death

  3. Number of Participant Infants Requiring Respiratory Support (Component of Primary Outcome)

    Time frame · Delivery through discharge

    Registry description

    Respiratory support includes mechanical ventilation, continuous positive airway pressure or high flow nasal cannula and cardiorespiratory resuscitation

  4. Number of Infants With Apgar Score ≤3 at 5 Minutes (Component of Primary Outcome)

    Time frame · Delivery through 5 minutes after birth

    Registry description

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.

  5. Number of Infants With Neonatal Hypoxic-ischemic Encelphalopathy (Component of Primary Outcome)

    Time frame · delivery through discharge

  6. Number of Infants With Neonatal Seizure (Component of Primary Outcome)

    Time frame · Delivery through discharge

  7. Number of Infants With Neonatal Infection (Component of Primary Outcome)

    Time frame · delivery through discharge

    Registry description

    Neonatal infection includes confirmed sepsis and/or confirmed pneumonia

  8. Number of Infants With Meconium Aspiration Syndrome (Component of Primary Outcome)

    Time frame · Delivery through discharge

  9. Number of Infants With Birth Trauma (Component of Primary Outcome)

    Time frame · During the Delivery process

    Registry description

    Birth trauma includes clavicular, skull or other fracture; brachial plexus palsy, facial nerve palsy, retinal hemorrhage or vocal cord paralysis

  10. Number of Infants With Intracranial or Subgaleal Hemorrhage (Component of Primary Outcome)

    Time frame · delivery through disharge

    Registry description

    Intracranial or subgaleal hemorrhage includes Intraventricular hemorrhage grades III or IV, subdural hematoma, subarachnoid hematoma, and subgaleal hematoma

  11. Hypotension Requiring Vasopressor Support (Component of Primary Outcome)

    Time frame · delivery through discharge

Secondary outcomes(20)
  1. Number of Participants With Cesarean Delivery

    Time frame · delivery

  2. Number of Participants Who Had Uterine Incisional Extension at Cesarean Delivery

    Time frame · delivery

    Registry description

    Incisional extensions at cesarean section, including J shape or T shape; or cervical traumas

  3. Participants Who Had Operative Vaginal Delivery

    Time frame · delivery

  4. Number of Participants Who Had Chorioamnionitis

    Time frame · at any time from randomization through delivery

    Registry description

    Chorioamnionitis, defined as a clinical diagnosis before delivery

  5. Number of Participants With Third or Fourth Degree Perineal Laceration

    Time frame · delivery

  6. Number of Maternal Deaths

    Time frame · from randomization to hospital discharge

    Registry description

    Maternal death at anytime between randomization and hospital discharge.

  7. Number of Participants Admitted to Intensive Care Unit (ICU)

    Time frame · delivery through hospital discharge

    Registry description

    Admission of the participant to the intensive care unit (ICU)

  8. Number of Participants Experiencing Hypertensive Disorder of Pregnancy

    Time frame · Randomization to hospital discharge

  9. Number of Participants With Postpartum Hemorrhage

    Time frame · delivery through hospital discharge

    Registry description

    defined as any of the following: * Transfusion * Non-elective hysterectomy * Use of two or more uterotonics other than oxytocin * Other surgical interventions such as uterine compression sutures, uterine artery ligation, embolization, hypogastric ligation, or balloon tamponade * Curettage

  10. Labor Agentry Scale Scores

    Time frame · Between 6 hours after delivery and 8 weeks after delivery

    Registry description

    Scores on the Labor Agentry Scale range from 29 to 203, with higher scores indicating greater perceived control during childbirth; included are women who had spontaneous labor, labor that started spontaneously but then was augmented, or induced labor.

  11. Labor Pain Scores

    Time frame · During labor and delivery

    Registry description

    Labor pain was scored according to a 10-point Likert scale, with higher scores indicating greater pain; included are women who had spontaneous labor, labor that started spontaneously but then was augmented, or induced labor.

  12. Number of Participants With Maternal Postpartum Infection

    Time frame · delivery through discharge

    Registry description

    Defined as any of the following: * Clinical diagnosis of endometritis * Wound reopened for hematoma, seroma, infection or other reasons * Cellulitis requiring antibiotics * Pneumonia * Pyelonephritis * Bacteremia - unknown source * Septic pelvic thrombosis

  13. Number of Participants With Venous Thromboembolism

    Time frame · delivery through discharge

    Registry description

    Maternal deep venous thrombosis or pulmonary embolism

  14. Number of Participants With Indications for Cesarean Delivery

    Time frame · Labor and delivery

    Registry description

    Number of participants with indications for cesarean delivery including dystocia, non-reassuring fetal status or other indication

  15. Duration of Respiratory Support

    Time frame · delivery through hospital discharge

    Registry description

    including ventilator, CPAP, high-flow nasal cannula (HFNC)

  16. Number of Infants With Cephalohematoma

    Time frame · delivery through hospital discharge

  17. Shoulder Dystocia

    Time frame · delivery

  18. Number of Infants Who Had Transfusion of Blood Products or Blood

    Time frame · delivery through hospital discharge

  19. Number of Infants With Hyperbilirubinemia

    Time frame · delivery through discharge

    Registry description

    Hyperbilirubinemia requiring phototherapy or exchange transfusion

  20. Number of Infants With Neonatal Hypoglycemia

    Time frame · delivery through discharge

    Registry description

    glucose \< 35 mg/dl and requiring IV therapy

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

Primary outcome results

Primary outcomeCount of participants· delivery through 72 hours after birth

Composite of Severe Neonatal Morbidity and Perinatal Mortality

GroupValue (Participants)
Expectant Management164
Elective Induction of Labor132
Primary outcomeCount of participants· antepartum pregnancy period through hospital discharge

Perinatal Death (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management3
Elective Induction of Labor2
Primary outcomeCount of participants· Delivery through discharge

Number of Participant Infants Requiring Respiratory Support (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management127
Elective Induction of Labor91
Primary outcomeCount of participants· Delivery through 5 minutes after birth

Number of Infants With Apgar Score ≤3 at 5 Minutes (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management18
Elective Induction of Labor12
Primary outcomeCount of participants· delivery through discharge

Number of Infants With Neonatal Hypoxic-ischemic Encelphalopathy (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management20
Elective Induction of Labor14
Primary outcomeCount of participants· Delivery through discharge

Number of Infants With Neonatal Seizure (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management4
Elective Induction of Labor11
Primary outcomeCount of participants· delivery through discharge

Number of Infants With Neonatal Infection (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management12
Elective Induction of Labor9
Primary outcomeCount of participants· Delivery through discharge

Number of Infants With Meconium Aspiration Syndrome (Component of Primary Outcome)

GroupValue (Participants)
Expectant Management26
Elective Induction of Labor17

Adverse events, as posted

Adverse events as posted: participants affected out of participants at risk, by group
GroupDeathsSerious eventsOther events
Expectant ManagementExpectant management (unless a medical indication arises) until at least 40 weeks 5 days.3 / 30593 / 30370 / 3037
Elective Induction of LaborElective induction of labor between 39 weeks 0 days and 39 weeks 4 days Elective Induction of Labor: Women randomized to induction of labor will undergo induction via oxytocin at 39 weeks 0 days to 39 weeks 4 days. Those with an unfavorable cervix (modified Bishop score \< 5) will first undergo cervical ripening (method left to the discretion of the patient's physician) in conjunction with or followed by oxytocin stimulation unless a contraindication arises.2 / 30372 / 30590 / 3059

Each cell reads participants affected / participants at risk, as the registry posted them.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Other registry references

References listed at the registry that are not in PepBank. They link to PubMed.

  • ResultGrobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566. PMID 30089070
  • DerivedMallett G, Hill K, Doherty L, Grobman WA, Reddy UM, Tita ATN, Silver RM, Rice MM, El-Sayed YY, Wapner RJ, Rouse DJ, Saade GR, Thorp JM Jr, Chauhan SP, Costantine MM, Chien EK, Casey BM, Srinivas SK, Swamy GK, Simhan HN, Macones GA; The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network*. Maternal and Delivery Characteristics and Self-Reported Perceived Control During Labor. Obstet Gynecol. 2023 Jul 1;142(1):117-124. doi: 10.1097/AOG.0000000000005230. PMID 37290106
  • DerivedCostantine MM, Sandoval GJ, Grobman WA, Reddy UM, Tita ATN, Silver RM, El-Sayed YY, Wapner RJ, Rouse DJ, Saade GR, Thorp JM Jr, Chauhan SP, Chien EK, Casey BM, Srinivas SK, Swamy GK, Simhan HN; for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Association of Body Mass Index With the Use of Health Care Resources in Low-Risk Nulliparous Pregnancies After 39 Weeks of Gestation. Obstet Gynecol. 2022 May 1;139(5):866-876. doi: 10.1097/AOG.0000000000004753. Epub 2022 Apr 5. PMID 35576345
  • DerivedSilver RM, Rice MM, Grobman WA, Reddy UM, Tita ATN, Mallett G, Hill K, Thom EA, El-Sayed YY, Wapner RJ, Rouse DJ, Saade GR, Thorp JM Jr, Chauhan SP, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network*. Customized Probability of Vaginal Delivery With Induction of Labor and Expectant Management in Nulliparous Women at 39 Weeks of Gestation. Obstet Gynecol. 2020 Oct;136(4):698-705. doi: 10.1097/AOG.0000000000004046. PMID 32925634
  • DerivedMallett G, Hill K, de Voest J, Bousleiman SZ, Allard D, Harris S, Salazar A, Clark K, Ortiz F, Bartholomew A, Dalton W, Craig J, Bickus M; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Characteristics Associated With Consent and Reasons for Declining in a Randomized Trial in Pregnancy. Obstet Gynecol. 2020 Oct;136(4):731-737. doi: 10.1097/AOG.0000000000003998. PMID 32925629
  • DerivedEl-Sayed YY, Rice MM, Grobman WA, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, Wapner RJ, Rouse DJ, Saade GR, Thorp JM Jr, Chauhan SP, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network*. Elective Labor Induction at 39 Weeks of Gestation Compared With Expectant Management: Factors Associated With Adverse Outcomes in Low-Risk Nulliparous Women. Obstet Gynecol. 2020 Oct;136(4):692-697. doi: 10.1097/AOG.0000000000004055. PMID 32925628
  • DerivedDude A, Fette LM, Reddy UM, Tita ATN, Silver RM, El-Sayed YY, Wapner RJ, Rouse DJ, Saade GR, Thorp JM Jr, Chauhan SP, Iams JD, Chien EK, Casey BM, Srinivas SK, Swamy GK, Simhan HN; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Maternal Sense of Control During Childbirth and Infant Feeding Method. Obstet Gynecol. 2020 Mar;135(3):583-590. doi: 10.1097/AOG.0000000000003697. PMID 32028504

Eligibility

Who could join, as posted.

Sex
Female
Age
Not stated
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: 1. Nulliparous - no previous pregnancy beyond 20 weeks 2. Singleton gestation. Twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age. 3. Gestational age at randomization between 38 weeks 0 days and 38 weeks 6 days inclusive based on clinical information and evaluation of the earliest ultrasound. Exclusion Criteria: 1. Project gestational age at date of first ultrasound is \> 20 weeks 6 days 2. Plan for induction of labor prior to 40 weeks 5 days 3. Plan for cesarean delivery or contraindication to labor 4. Breech presentation 5. Signs of labor (regular painful contractions with cervical change) 6. Fetal demise or known major fetal anomaly 7. Heparin or low-molecular weight heparin during the current pregnancy 8. Placenta previa, accreta, vasa previa 9. Active vaginal bleeding greater than bloody show 10. Ruptured membranes 11. Cerclage in current pregnancy 12. Known oligohydramnios, defined as AFI \< 5 or MVP \< 2 13. Fetal growth restriction, defined as EFW \< 10th percentile 14. Known HIV positivity because of modified delivery plan 15. Major maternal medical illness associated with increased risk for adverse pregnancy outcome (for example, any diabetes mellitus, lupus, any hypertensive disorder, cardiac disease, renal insufficiency) 16. Refusal of blood products 17. Participation in another interventional study that influences management of labor at delivery or perinatal morbidity or mortality 18. Delivery planned elsewhere at a non-Network site

PepBank is a research reference. Talk to a doctor before you use any peptide.